Pregled bibliografske jedinice broj: 358999
Antifosfolipidni sindrom: od dijagnoze do liječenja.
Antifosfolipidni sindrom: od dijagnoze do liječenja. // Liječnički Vjesnik, 129 (2007), 8-9; 281-285 (podatak o recenziji nije dostupan, pregledni rad, ostalo)
CROSBI ID: 358999 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Antifosfolipidni sindrom: od dijagnoze do liječenja.
(Antiphospholipid syndrome: from diagnosis to treatment)
Autori
Martinović D, Radić D, Fabijanić D, Fabijanić A.
Izvornik
Liječnički Vjesnik (0024-3477) 129
(2007), 8-9;
281-285
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, ostalo
Ključne riječi
antifosfolipidni sindrom; dijagnoza; liječenje
(antiphospholipid syndrome; diagnosis; treatment)
Sažetak
Antiphospholipid syndrome (APS) is a prothrombotic disorder mediate with characteristic antiphospholipide antibodies (aPL). Patients with APS have got higher risk for arterial or venous thromboembolism. However, in spite of numerous studies the true association between aPL and first thromboembolism is still unknown. It is not clear whether the presence of aPL is a risk factor for thromboembolism or do they directly take a part in thrombogenesis. Many patients with aPL never experienced thromboembolic event. So far there is not any recommendation for primary prophylaxis of thromboembolic complications in such patients. Guidelines for secondary prevention recommended permanent anticoagulation. In this paper we offer a concise review of the vast body of published work and appropriateness of anticoagulation or antiplatelat therapy in various clinical subcategories of this syndrome.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Split
Citiraj ovu publikaciju:
Časopis indeksira:
- Scopus
- MEDLINE
Uključenost u ostale bibliografske baze podataka::
- MEDLINE